Filing Details
- Accession Number:
- 0001213900-20-045810
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-12-31 17:25:04
- Reporting Period:
- 2020-12-29
- Accepted Time:
- 2020-12-31 17:25:04
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1218683 | Wize Pharma Inc. | WIZP | Pharmaceutical Preparations (2834) | 880445167 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1721808 | Ltd Assets Gold Rimon | C/O Wize Pharma, Inc. 24 Hanagar Street Hod Hasharon L3 4527708 | No | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-12-29 | 400,000 | $0.00 | 4,002,925 | No | 4 | X | Direct | |
| Common Stock | Disposition | 2020-12-29 | 3,077 | $0.00 | 3,999,848 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2020-12-29 | 3,385,212 | $0.00 | 7,385,060 | No | 4 | X | Direct | |
| Common Stock | Disposition | 2020-12-29 | 28,210 | $0.00 | 7,356,850 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2020-12-29 | 520,820 | $0.00 | 7,877,670 | No | 4 | X | Direct | |
| Common Stock | Disposition | 2020-12-29 | 4,340 | $0.00 | 7,873,330 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2020-12-29 | 350,334 | $0.00 | 7,522,996 | No | 4 | X | Direct | |
| Common Stock | Disposition | 2020-12-29 | 2,919 | $0.00 | 7,520,077 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | X | Direct | |
| No | 4 | S | Direct | |
| No | 4 | X | Direct | |
| No | 4 | S | Direct | |
| No | 4 | X | Direct | |
| No | 4 | S | Direct | |
| No | 4 | X | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Warrant (right to buy) | Disposition | 2020-12-29 | 400,000 | $0.00 | 400,000 | $0.16 |
| Common Stock | Warrant (right to buy) | Disposition | 2020-12-29 | 3,385,212 | $0.00 | 3,385,212 | $0.27 |
| Common Stock | Warrant (right to buy) | Disposition | 2020-12-29 | 520,820 | $0.00 | 520,820 | $0.16 |
| Common Stock | Future Investment Rights | Disposition | 2020-12-29 | 350,334 | $0.00 | 350,334 | $0.27 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2019-04-21 | 2023-10-23 | No | 4 | X | Direct |
| 0 | 2024-12-12 | No | 4 | X | Direct | |
| 0 | 2019-05-31 | 2021-05-30 | No | 4 | X | Direct |
| 0 | 2019-12-13 | 2024-12-12 | No | 4 | X | Direct |
Footnotes
- On December 23, 2020 the registrant has voluntary reduced the exercise price of warrants to $0.001. The reporting person exercised a warrant to purchase shares of the registrant's common stock for the reduced exercise price.
- On December 29, 2020 the reporting person exercised a warrant to purchase 400,000 shares of the registrant's common stock for $0.16 a share. The reporting person paid the exercise price on a cashless basis, resulting in the registrant withholding of 3,077 of the warrant shares to pay the exercise price and issuing to the reporting person the remaining 396,923 shares.
- On December 29, 2020 the reporting person exercised a warrant to purchase 3,385,212 shares of the registrant's common stock for $0.27 a share. The reporting person paid the exercise price on a cashless basis, resulting in the registrant withholding of 28,210 of the warrant shares to pay the exercise price and issuing to the reporting person the remaining 3,357,002 shares.
- On December 29, 2020 the reporting person exercised a warrant to purchase 520,820 shares of the registrant's common stock for $0.16 a share. The reporting person paid the exercise price on a cashless basis, resulting in the registrant withholding of 4,340 of the warrant shares to pay the exercise price and issuing to the reporting person the remaining 516,480 shares.
- On December 29, 2020 the reporting person exercised a warrant to purchase 350,334 shares of the registrant's common stock for $0.27 a share. The reporting person paid the exercise price on a cashless basis, resulting in the registrant withholding of 2,919 of the warrant shares to pay the exercise price and issuing to the reporting person the remaining 347,415 shares.
- Exercisable five days following the public announcement of positive clinical data results for LO2A.
Billionaire Hedge Funds
